Temporal ordering of pathogenic events following transient global ischemia

Brain Research

Volumn 790, Issue 1-2, 1998, Pages 1-13

  Bartus, Raymond T ^a,e   Dean, Reginald L ^a   Mennerick, Steve ^b   Eveleth, David ^c   Lynch, Gary ^d  

^a ALKERMES INC   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BAYER CORPORATION   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e TUFTS MEDICAL CENTER   (United States)

Author keywords

Calpain proteolysis; Cytoskeleton; Delayed cell death; Field potentials; Hippocampus; Selective vulnerability; Silver stain; Spectrin

Indexed keywords

CALPAIN; SPECTRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CALCIUM CELL LEVEL; CELL DEATH; CONTROLLED STUDY; CYTOSKELETON; HIPPOCAMPUS; NERVE DEGENERATION; NONHUMAN; PATHOGENICITY; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PYRAMIDAL NERVE CELL; RAT;

ANIMALS; BRAIN CHEMISTRY; CALPAIN; CELL DEATH; CYTOSKELETON; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; ISCHEMIC ATTACK, TRANSIENT; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; SILVER STAINING; SPECTRIN; TIME FACTORS;

EID: 0032550159     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01414-5     Document Type: Article

References (43)

1. P. Andine, O. Owe, I. Jacobson, M. Sandberg, H. Hagberg, Changes in extracellular amino acids and spontaneous neuronal activity during ischemia and extended reflow in the CA1 of the rat hippocampus, J. Neurochem. 57 (1991) 222-229.
2. A. Arai, M. Kessler, K. Lee, G. Lynch, Calpain inhibitors improve the recovery of synaptic transmission from hypoxia in hippocampal slices, Brain Res. 532 (1990) 63-68.
3. P.R. Bar, M.F. Seal (Eds.), Neuroprotection in CNS Diseases, Marcel Dekker, New York, 1997.
4. R.T. Bartus, N.J. Hayward, P.J. Elliott, S.D. Sawyer, K.L. Baker, R.L. Dean, A. Akiyama, J.A. Straub, S.L. Harbeson, Z. Li, J. Powers, Calpain inhibitor AK295 protects neurons from focal brain ischemia effects of postocclusion intra-arterial administration, Stroke 25 (1994) 2265-2270.
5. R.T. Bartus, K.L. Baker, A.D. Heiser, S.D. Sawyer, R.L. Dean, P.J. Elliott, J.A. Straub, Postischemic administration of AK275, a calpain inhibitor, provides substantial protection against focal ischemic brain damage, J. Cereb. Blood Flow Metab. 14 (1994) 537-544.
6. R.T. Bartus, R.L. Dean, K. Cavanaugh, D. Eveleth, D. Carriero, G. Lynch, Time-related neuronal changes following middle cerebral artery occlusion: implications for therapeutic intervention and the role of calpain, J. Cereb. Blood Flow Metab. 15 (1995) 969-979.
7. R.T. Bartus, P.J. Elliott, N.J. Hayward, R.L. Dean, S. Harbeson, J.A. Straub, Z. Li, J.C. Powers, Calpain as a novel target for treating acute neurodegenerative disorders, Neuro. Res. 17 (1995) 249-258.
8. R.T. Bartus, The calpain hypothesis of neurodegeneration: evidence for a common cytotoxic pathway, The Neuroscient. 3 (1997) 314-327.
9. H. Benveniste, M.B. Jorgensen, M. Sandberg, T. Christensen, H. Hagberg, N.H. Diemer, Ischemic damage in hippocampal CA1 is dependent on glutamate release and intact innervation from CA3, J. Cereb. Blood Flow Metab. 9 (1989) 629-639.
10. X. Bi, V. Chang, E. Molnar, R.A.J. Mcllhinney, M. Baudry, The c-terminal domain of glutamate receptor subunit 1 is a target for calpain-mediated proteolysis, Neuroscience 73 (1996) 903-906.
11. G. Buzsaki, Freund, F. Bayardo, P. Somorgyi, Ischemia-induced changes in the electrical activity of the hippocampus, Exp. Brain Res. 78 (1989) 268-278.
12. H.S. Chang, T. Sasaki, N.F. Kassell, Hippocampal unit activity after transient cerebral ischemia in rats, Stroke 20 (1989) 1051-1058.
13. D.W. Choi, Glutamate neurotoxicity and diseases of the nervous system, Neuron 1 (1988) 623-634.
14. B.J. Crain, W.D. Westerkam, A.H. Harrison, J.V. Nadler, Selective neuronal death after transient forebrain ischemia in the mongolian gerbil: a silver impregnation study, Neuroscience 27 (1988) 387-402.
15. F. Gallyas, J.R. Wolff, H. Bottcher, L. Zaborszkyl, A reliable and sensitive method to localize terminal degeneration and lysosomes in the central nervous system, Stain Technol. 55 (1980) 299-306.
16. M.D. Ginsberg, R. Busto, Rodent models of cerebral ischemia, Stroke 20 (1989) 1627-1642.
17. S.H. Graham, K. Shiraishi, S.S. Panter, R.P. Simon, A.I. Fade, Changes in extracellular amino acid neurotransmitters produced by focal cerebral ischemia, Neurosci. Lett., 110 (1-2) 124-130.
18. H. Imon, A. Mitani, Y. Andou, T. Arai, K. Kataoka, Delayed neuronal death is induced without postischemic hyperexcitability: continuous multiple unit recording from ischemic CA1 neurons, J. Cereb. Blood Flow Metab. 11 (1991) 819-823.
19. G.V.W. Johnson, J.M. Litersky, R.S. Jope, Degradation of microtubule-associated protein 2 and brain spectrin by calpain: a comparative study, J. Neurochem. 56 (1991) 1630-1638.
20. K.S. Lee, S. Frank, P. Vanderklish, A. Arai, G. Lynch, Inhibition of proteolysis protects hippocampal neurons from ischemia, Proc. Natl. Acad. Sci. 88 (1991) 7233-7237.
21. B.W. Lin, W.D. Dietrich, R. Busto, M.D. Ginsberg, (S)-emopamil protects against global ischemic brain injury in rats, Stroke 12 (1990) 1734-1739.
22. G. Lynch, J. Larson, M. Baudry, Proteases, neuronal stability, and brain aging: a hypothesis, in: T. Crook, R.T. Bartus, S. Ferris, S. Gershon (Eds.), Treatment Development Strategies for Alzheimer's Disease, Mark Powley Associates, Madison, CT, 1986, pp. 119-149.
23. B.S. Meldrum, Possible therapeutic applications of antagonists of excitatory amino acid neurotransmitter, Clin. Sci. 68 (1985) 113-122.
24. J.V. Nadler, D.A. Evenson, Use of excitatory amino acids to make axon-sparing lesions in the hypothalamus, Meth. Enzymol. 103 (1983) 393-400.
25. W.A. Pulsinelli, J.B. Brierley, A new model of bilateral hemispheric ischemia in the unanesthetized rat, Stroke 10 (1989) 267-272.
26. W.A. Pulsinelli, J.B. Brierley, F. Plum, Temporal profile of neuronal damage in a model of transient forebrain ischemia, Ann. Neurol. 11 (1991) 491-498.
27. W.A. Pulsinelli, D.E. Levy, T.E. Duffy, Regional cerebral blood flow and glucose metabolism following transient forebrain ischemia, Ann. Neurol. 11 (1982) 499-509.
28. A. Rami, J. Krieglstein, Protective effects of calpain inhibitors against neuronal damage caused by cytotoxic hypoxia in vitro and ischemia in vivo, Brain Res. 609 (1993) 67-70.
29. J.M. Roberts-Lewis, M.J. Savage, V.R. Marcy, L.R. Pinsker, R. Siman, Immunolocalization of calpain I-mediated spectrin degradation to vulnerable neurons in the ischemic gerbil brain, J. Neurosci. 14 (1994) 3934-3944.
30. T.C. Saido, M. Yokota, S. Nagao, I. Yamaura, E. Tani, T. Tsuchiya, K. Suzuki, S. Kawashima, Spatial resolution of fodrin proteolysis in postischemic brain, J. Biol. Chem. 268 (33) (1993) 25239-25243.
31. P. Seubert, G. Ivy, J. Larson, J. Lee, K. Shahi, M. Baudry, G. Lynch, Lesions of entorhinal cortex produce a calpain-mediated degradation of brain spectrin in dentate gyrus: I. Biochemical studies, Brain Res. 459 (1988) 226-232.
32. P. Seubert, K. Lee, G. Lynch, Ischemia triggers NMDA receptor-linked cytoskeletal proteolysis in hippocampus, Brain Res. 492 (1989) 366-370.
33. B.K. Siesjo, F. Bengtsson, Calcium fluxes, calcium antagonists, and calcium-related pathology in brain ischemia, hypoglycemia, and spreading depression: a unifying hypothesis, J. Cereb. Blood Flow Metab. 9 (1989) 127-140.
34. R. Siman, M. Baudry, G. Lynch, Brain fodrin: substrate for calpain I, an endogenous calcium-activated protease, Proc. Natl. Acad. Sci. 81 (1984) 3572-3576.
35. R. Siman, C. Gall, L.S. Perlmutter, C. Christian, M. Baudry, G. Lynch, Distribution of calpain I, an enzyme associated with degenerative activity, in rat brain, Brain Res. 347 (1985) 399-403.
36. R. Siman, J.C. Noszek, C. Kegerise, Calpain I activation is specifically related to excitatory amino acid induction of hippocampal damage, J. Neurosci. 9 (1989) 1579-1590.
37. R.S. Sloviter, Calcium-binding protein (calbindin-D28k) and parvalbumin immunocytochemistry: localization in the rat hippocampus with specific references to the selective vulnerability of hippocampal neurons to seizure activity, J. Comp. Neurol. 280 (1989) 183-196.
38. M.L. Smith, R.N. Auer, B.K. Siesgo, The density and distribution of ischemic brain injury in the rat following 2-10 min of forebrain ischemia, Acta Neuropathol. 64 (1984) 319-332.
39. R. Suzuki, T. Yamaguchi, C.L. Li, I. Klatzo, The effects of 5-minute ischemia in mongolian gerbils: II. Changes of spontaneous neuronal activity in cerebral cortex and CA1 sector hippocampus, Acta Neuropathol. 6 (1983) 217-222.
40. K. Takahashi, Calpain substrate specificity, in: R.L. Mellgren, T. Murachi (Eds.), Intracellular Calcium Dependent Proteolysis, CRC Press, Boca Raton, FL, 1990, pp. 55-74.
41. R. Torp, D. Lekieffre, L.M. Levy, F.M. Huag, N.C. Danbolt, B.S. Meldrum, O.P. Ottersen, Reduced postischemic expression of a glial glutamate transporter, GLT1, in the rat hippocampus, Exp. Brain Res. 103 (1995) 51-58.
42. L. Urban, K.H. Neill, B.J. Grain, J.V. Nadler, G.G. Somjan, Postischemic synaptic physiology in area CA1 of the gerbil hippocampus studied in vitro, J. Neurosci. 9 (1989) 3966-3975.
43. K. Valentino, R. Newcomb, T. Gadbois, T. Singh, S. Bowersox, S. Bitner, A. Justice, D. Yamashiro, B.B. Hoffman, R. Ciaranello, G. Miljanich, J. Ramachandran, A selective N-type calcium channel antagonist protects against neuronal loss after global cerebral ischemia, Proc. Natl. Acad. Sci. 90 (1993) 7894-7897.